Skip to content

Drug interactions

Pazopanib + Rucaparib

Severity: Moderate

Pazopanib and Rucaparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a moderate CYP3A4 inhibitor and may raise pazopanib exposure. Pazopanib toxicities such as hepatotoxicity and hypertension may be increased.

What this interaction means in plain words

Pazopanib and Rucaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pazopanib belongs to Oncology; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Rucaparib inhibits CYP3A4, reducing pazopanib metabolism.

What to do

Monitor liver function and blood pressure, and reduce the pazopanib dose if adverse effects emerge.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pazopanib and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pazopanib with Rucaparib?

MediHelp rates the interaction as moderate. Pazopanib and Rucaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rucaparib is a moderate CYP3A4 inhibitor and may raise pazopanib exposure. Pazopanib toxicities such as hepatotoxicity and hypertension may be increased.

How serious is the interaction between Pazopanib and Rucaparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver function and blood pressure, and reduce the pazopanib dose if adverse effects emerge.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in